P

Inventor

REMILLARD ROGER

US20 patents
⚠️ This page may combine multiple inventors who share the name “REMILLARD ROGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

13 patents
US7192948B2Mar 20, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO34 citations92
US7176196B2Feb 13, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO35 citations92
US7157447B2Jan 2, 2007

Bicyclic heterocycles as HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO30 citations92
US7109186B2Sep 19, 2006

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO27 citations91
US6777440B2Aug 17, 2004

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO14 citations84
US10822343B2Nov 3, 2020

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO4 citations83
US10428077B2Oct 1, 2019

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO8 citations83
US10047103B2Aug 14, 2018

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

BRISTOL MYERS SQUIBB CO11 citations83
US7494984B2Feb 24, 2009

Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors

BRISTOL MYERS SQUIBB CO8 citations83
US7511037B2Mar 31, 2009

N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor

BRISTOL MYERS SQUIBB CO7 citations73
US6890942B2May 10, 2005

Acyl sulfonamides as inhibitors of HIV integrase

BRISTOL MYERS SQUIBB CO9 citations72
US7893055B2Feb 22, 2011

HIV integrase inhibitors

BRISTOL MYERS SQUIBB CO4 citations61
US6924391B2Aug 2, 2005

Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors

BRISTOL MYERS SQUIBB CO2 citations61

VISCORP

7 patents